XML 38 R25.htm IDEA: XBRL DOCUMENT
v3.23.2

Earnings Per Share | 12 Months Ended
--- | ---
Dec. 31, 2022
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share Basic earnings per share is calculated using the weighted average number of shares of the Company’s common stock issued and outstanding during a certain period, and is calculated by dividing net income attributable to ApolloMed by the weighted average number of shares of the Company’s common stock issued and outstanding during such period. Diluted earnings per share is calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes, preferred stock, and the treasury stock method for options and common stock warrants. The non-controlling interests in APC are allocated their share of ApolloMed’s income from APC’s ownership of ApolloMed common stock and this is included in the net income attributable to non-controlling interests on the consolidated statements of income. Therefore, none of the shares of ApolloMed held by APC are considered outstanding for the purposes of basic or diluted earnings per share computation. As of December 31, 2022, 2021, and 2020, APC held 10,299,259, 10,925,702 and 12,323,164 shares of ApolloMed's common stock, respectively, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share. For the years ended December 31, 2022, 2021, and 2020, restricted stock of 133,480, 9,137, and 212,276, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being anti-dilutive. For the year ended December 31, 2022, 245,478 of restricted stock with performance conditions were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of December 31, 2022. Below is a summary of the earnings per share computations:
|  | Years ended December 31,
|  | 2022 |  | 2021 |  | 2020
Earnings per share – basic (restated) |  | $ | 1.00 |  |  | $ | 1.57 |  |  | $ | 1.03 |
Earnings per share – diluted (restated) |  | $ | 0.99 |  |  | $ | 1.52 |  |  | $ | 1.01 |
Weighted-average shares of common stock outstanding – basic |  | 44,971,143 |  |  | 43,828,664 |  |  | 36,527,672 |
Weighted-average shares of common stock outstanding – diluted |  | 45,602,415 |  |  | 45,403,085 |  |  | 37,448,430 |
Below is a summary of the shares included in the diluted earnings per share computations:
|  | Years ended December 31,
|  | 2022 |  | 2021 |  | 2020
Weighted-average shares of common stock outstanding – basic |  | 44,971,143 |  |  | 43,828,664 |  |  | 36,527,672 |
Stock options |  | 439,309 |  |  | 495,618 |  |  | 182,999 |
Warrants |  | — |  |  | 819,151 |  |  | 717,029 |
Restricted stock awards |  | 161,648 |  |  | 259,652 |  |  | 20,730 |
Contingently issuable shares |  | 30,315 |  |  | — |  |  | — |
Weighted-average shares of common stock outstanding – diluted |  | 45,602,415 |  |  | 45,403,085 |  |  | 37,448,430 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration